Back
Adaptive Biotechnologies 10K Form
Sell
33
ADPT
Adaptive Biotechnologies
Last Price:
$6.82
Seasonality Move:
11.6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-09 | 10Q | ADPT/Adaptive Biotechnologies Quarterly |
2023-08-02 | 10Q | ADPT/Adaptive Biotechnologies Quarterly |
2023-05-03 | 10Q | ADPT/Adaptive Biotechnologies Quarterly |
2022-11-03 | 10Q | ADPT/Adaptive Biotechnologies Quarterly |
2022-08-03 | 10Q | ADPT/Adaptive Biotechnologies Quarterly |
2022-05-04 | 10Q | ADPT/Adaptive Biotechnologies Quarterly |
Receive ADPT News And Ratings
See the #1 stock for the next 7 days that we like better than ADPT
ADPT Financial Statistics
Sales & Book Value
Annual Sales: | $179M |
---|---|
Cash Flow: | $-12.6M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.37 |
Price / Book: | 5.01 |
Profitability
EPS (TTM): | -1.09000 |
---|---|
Net Income (TTM): | $-159.5M |
Gross Margin: | $106.9M |
Return on Equity: | -63.77% |
Return on Assets: | -26.9% |
Adaptive Biotechnologies Earnings Forecast
Key Adaptive Biotechnologies Financial Ratios
-
The Gross Profit Margin over the past 19 years for ADPT is 59.72%.
-
The Selling, General & Administrative Expenses for ADPT have been equal to 88.05% of Gross Profit Margin.
-
The Research & Development expenses have been 57.53% of Revenue.
-
The Net Earning history of ADPT is -89.12% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 6 years.
Adaptive Biotechnologies Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Life Sciences Tools & Services |
Sector: | Health Care |
Current Symbol: | ADPT |
CUSIP: | 00650F |
Website: | adaptivebiotech.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 2.89 |
Quick Ratio: | 2.69 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
ADPT Technical Analysis vs Fundamental Analysis
Sell
33
Adaptive Biotechnologies (ADPT)
is a Sell
Is Adaptive Biotechnologies a Buy or a Sell?
-
Adaptive Biotechnologies stock is rated a SellThe current Adaptive Biotechnologies [ADPT] share price is $6.83. The Score for ADPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.